152results about How to "More convenient" patented technology

A method of controlling a mobile device configured with a touch-sensitive display and a motion sensor is provided. The method includes: the step of detecting a contact with the touch-sensitive display while the mobile device is in a first state to determine whether the detected contact corresponds to a predefined icon; the step of detecting a rotation or movement with the motion sensor while the mobile device is in the first state to determine whether the detected rotation or the movement corresponds to a predefined gesture; and the step of transitioning the mobile device to a second state when the detected contact corresponds to the predefined icon, and the detected rotation or movement corresponds to the predefined gesture. The mobile device is also provided.

The present invention features compositions, methods, and kits useful in the treatment of viral diseases. In certain embodiments, the viral disease is caused by a single stranded RNA virus, a flaviviridae virus, or a hepatic virus. In particular embodiments, the viral disease is viral hepatitis (e.g., hepatitis A, hepatitis B, hepatitis C, hepatitis D, hepatitis E) and the agent or combination of agents includes sertraline, a sertraline analog, UK-416244, or a UK-416244 analog. Also featured are screening methods for identification of novel compounds that may be used to treat a viral disease.

The invention features a method for treating a patient diagnosed with, or at risk of developing, an immunoinflammatory disorder by administering a non-steroidal immunophilin-dependent immunosuppressant (NsIDI) and a Group A enhancer (e.g., antifungal agent, antigout agent, anti-infective agent, antiprotozoal agent, antiviral agent, humectant, sunscreen, vitamin D compound, microtubuline inhibitor, or zinc salt) or analog or metabolite thereof to the patient. The invention also features a pharmaceutical composition containing an NsIDI and Group A enhancer or analog or metabolite thereof for the treatment or prevention of an immunoinflammatory disorder.

The invention features a method for treating a patient diagnosed with, or at risk of developing, an immunoinflammatory disorder by administering to the patient an antihistamine, either alone or in combination with one or more additional agents. The invention also features a pharmaceutical composition containing an antihistamine in combination with one or more additional agents.

Methods, systems, computer-readable media, and apparatuses for obtaining updated navigation information are presented. A first computing device can receive routing information from a second computing device, where the routing information is indicative of a route determined by the second computing device to a destination. Subsequently, navigation instructions can be provided at the first computing device based upon the routing information received from the second computing device. The first computing device then can receive, from the second computing device, a change to the routing information. Thereafter, and responsive to receiving the change to the routing information, the first computing device can provide modified navigation instructions.

The present invention relates to pharmaceutical dosage forms of a combination of carbidopa and levodopa comprising both immediate release and controlled release components for the treatment of ailments associated with depleted amounts of dopamine in a patient's brain tissue, which dosage forms display no food effect or at least substantially avoid the food effect, and a related method of treatment for a patient in which the bioavailability of levodopa under non-fasting conditions is equivalent to the bioavailability under fasting conditions.

PCT No. PCT / GB94 / 00865 Sec. 371 Date Feb. 18, 1997 Sec. 102(e) Date Feb. 18, 1997 PCT Filed Apr. 22, 1994 PCT Pub. No. WO94 / 25286 PCT Pub. Date Nov. 10, 1994Folded sheet means (201, 10) (e.g. substantially one-half or one-third of credit card size) (e.g. in the form of a kit of parts) comprises a sheet (221, 12) of paper or like material with a first set of concertina folds (261, 14) and a second set of concertina folds (281, 16) transverse to the first set, at which folds (261, 281, 14, 16) the sheet (221, 12) can be folded and unfolded, connection means (1061, 52) adapted to serve as or as part of means for releasably connecting between the folded sheet means (201, 10) and another object, and holding means (241, 22, 24) adapted for releasably holding the folded sheet means folded. Said holding means comprises an envelope or other container (241), said sheet (221) being adapted to be retained therein, e.g. with the aid of friction and / or at least one inwardly directed lip (341). The folded sheet material (221) may be (e.g. removably) in a carrier (961) movable into and out from the container (241). A tail (1061) suitable for connection to a key-ring, luggage or other portable object is provided, e.g. on the carrier (961). The container (241) may comprise two sheet-like portions (401, 421) hinged together and adapted to be releasably fastened together about the folded sheet (221). Two stiff portions (18, 20) are in diagonally opposite corners respectively of the sheet (12) when it is unfolded, and said holding means comprise a releasable connection (22), e.g. two tongues (26, 28) extending from one of said stiff portions (18) inwardly thereof in opposite directions. Part or all of the connection means (522, 523, 662) may be provided in common with part or all of the holding means (522,523, 662). The folded sheet means (10) may have a back portion (138) provided with releasable self-adhesive material for attaching it to a holding surface (107) and a front portion (208) adapted for grasping and opening the sheet (12).

The invention features methods, compositions, and kits for treating a musculoskeletal disorder, e.g., osteoarthritis, or pain, fatigue, tenderness, impairment in mobility, soft tissue swelling, or bony swelling associated therewith, by administering to a patient diagnosed with or at risk of developing such pain, fatigue, tenderness, impairment in mobility, soft tissue swelling, or bony swelling a tetra-substituted pyrimidopyrimidine, e.g., dipyridamole, or an adenosine activity upregulator, in combination with one or more additional agents. The invention further features methods, compositions, and kits for treating a patient diagnosed with or at risk of developing a musculoskeletal disorder by administering to the patient a tetra-substituted pyrimidopyrimidine or an adenosine activity upregulator in combination with one or more additional agents.